The economic aspects of the pharmaceutical industry in the United States : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 25, 2003.

The FDA and the future of American biomedical and food industries : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session, on examining activities of the Food and Drug Afministration focusing on the challenges and opportunities facing the pharmaceutical, biotech, medical device, and food industries, and FDA's regulation of these industries, April 5 and 6, 1995.

United States. Congress. Senate. Committee on Labor and Human Resources.

January 1995

Shipping list no.: 95-0243-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Medicare regulatory and contracting reform : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Eighth Congress, first session, February, 13, 2003.

United States. Congress. House. Committee on Ways and Means. Subcommittee on Health.

January 2003

"Serial no. 108-4."Shipping list no.: 2003-0220-P.Distributed to some depository libraries in microf...

Policy implications of pharmaceutical importation for U.S. consumers : hearing before the Subcommittee on Interstate Commerce, Trade, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Tenth Congress, first session, March 7, 2007.

United States. Congress. Senate. Committee on Commerce, Science, and Transportation. Subcommittee on Interstate Commerce, Trade, and Tourism.

January 2013

Shipping list no.: 2013-0150-P.Includes bibliographical references.Mode of access: Internet

Recent developments which may impact consumer access to, and demand for, pharmaceuticals : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 13, 2001.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.

January 2001

"Serial no. 107-34."Shipping list no.: 2002-0017-P.Distributed to depository libraries in microfiche...

The cost to the U.S. economy of drug abuse : hearings before the Subcommittee on Economic Goals and Intergovernmental Policy of the Joint Economic Committee, Congress of the United States, Ninety-ninth Congress, first session, August 6, 7, and 8, 1985.

United States. Congress. Joint Economic Committee. Subcommittee on Economic Goals and Intergovernmental Policy.

January 1986

Item 1000-B, 1000-C (microfiche)Shipping list no.: 86-947-P.Distributed to some depository libraries...

Perspectives on pharmaceutical pricing practices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, September 19, 1996.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

January 1996

"Serial no. 104-113."Shipping list no.: 97-0072-P.Distributed to some depository libraries in microf...

Competitive problems in the pharmaceutical drug industry : hearing before the Subcommittee on Antitrust, Monopolies [sic], and Business Rights of the Committee on the Judiciary, United States Senate, One Hundredth Congress, first session, on the generic drug industry and its concerns with respect to competition from the brand name manufacturers, October 21, 1987.

United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopoly, and Business Rights.

January 1989

"Serial no. J-100-40".Includes bibliographical references.Mode of access: Internet

Pharmaceutical supply chain security : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, July 11, 2006.

United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.

January 2007

"Serial no. 109-227."Shipping list no.: 2007-0357-P.Distributed to some depository libraries in micr...

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.

United States. Congress. Senate. Committee on the Judiciary.

January 2004

"Serial no. J-108-34."Shipping list no.: 2004-0161-P.Distributed to some depository libraries in mic...

Drug safety and pricing : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... June 13, 2000.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2000

Shipping list no.: 2001-0035-P.Distributed to some depository libraries in microfiche.Includes bibli...

Pharmaceutical marketplace reform : is competition the right prescription? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, November 16, 1993.

United States. Congress. Senate. Special Committee on Aging.

January 1994

"Serial no. 103-15."Shipping list no.: 94-0071-P.Distributed to some depository libraries in microfi...

Health insurance : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eighth Congress, first session : special hearing, May 14, 2003, Washington, DC.

United States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.

January 2003

Shipping list no.: 2004-0072-P.Distributed to some depository libraries in microfiche."Printed for t...

Technology, innovation, and health care costs : hearing before the Joint Economic Committee, Congress of the United States, One Hundred Eighth Congress, first session, July 9, 2003.

United States. Congress. Joint Economic Committee.

January 2003

Shipping list no.: 2004-0109-P.Distributed to some depository libraries in microfiche."Printed for t...

International trade and pharmaceuticals : joint hearing before the Subcommittee on International Trade and the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, April 27, 2004.

United States. Congress. Senate. Committee on Finance. Subcommittee on International Trade.
United States. Congress. Senate. Committee on Finance. Subcommittee on Health Care.

January 2004

Shipping list no.: 2005-0152-P.Distributed to some depository libraries in microfiche.Includes bibli...

Prescription drug costs : what drives increases? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, 106th Congress, 2nd session ... July 18, 2000.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2000

Shipping list no.: 2001-0024-P.Distributed to some depository libraries in microfiche."Printed for t...

The FDA and the future of American biomedical and food industries : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session, on examining activities of the Food and Drug Afministration focusing on the challenges and opportunities facing the pharmaceutical, biotech, medical device, and food industries, and FDA's regulation of these industries, April 5 and 6, 1995.

United States. Congress. Senate. Committee on Labor and Human Resources.

January 1995

Shipping list no.: 95-0243-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Medicare regulatory and contracting reform : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Eighth Congress, first session, February, 13, 2003.

United States. Congress. House. Committee on Ways and Means. Subcommittee on Health.

January 2003

"Serial no. 108-4."Shipping list no.: 2003-0220-P.Distributed to some depository libraries in microf...

Policy implications of pharmaceutical importation for U.S. consumers : hearing before the Subcommittee on Interstate Commerce, Trade, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Tenth Congress, first session, March 7, 2007.

United States. Congress. Senate. Committee on Commerce, Science, and Transportation. Subcommittee on Interstate Commerce, Trade, and Tourism.

January 2013

Shipping list no.: 2013-0150-P.Includes bibliographical references.Mode of access: Internet

Recent developments which may impact consumer access to, and demand for, pharmaceuticals : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 13, 2001.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.

January 2001

"Serial no. 107-34."Shipping list no.: 2002-0017-P.Distributed to depository libraries in microfiche...

The cost to the U.S. economy of drug abuse : hearings before the Subcommittee on Economic Goals and Intergovernmental Policy of the Joint Economic Committee, Congress of the United States, Ninety-ninth Congress, first session, August 6, 7, and 8, 1985.

United States. Congress. Joint Economic Committee. Subcommittee on Economic Goals and Intergovernmental Policy.

January 1986

Item 1000-B, 1000-C (microfiche)Shipping list no.: 86-947-P.Distributed to some depository libraries...

Perspectives on pharmaceutical pricing practices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, September 19, 1996.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

January 1996

"Serial no. 104-113."Shipping list no.: 97-0072-P.Distributed to some depository libraries in microf...

Competitive problems in the pharmaceutical drug industry : hearing before the Subcommittee on Antitrust, Monopolies [sic], and Business Rights of the Committee on the Judiciary, United States Senate, One Hundredth Congress, first session, on the generic drug industry and its concerns with respect to competition from the brand name manufacturers, October 21, 1987.

United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopoly, and Business Rights.

January 1989

"Serial no. J-100-40".Includes bibliographical references.Mode of access: Internet

Pharmaceutical supply chain security : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, July 11, 2006.

United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.

January 2007

"Serial no. 109-227."Shipping list no.: 2007-0357-P.Distributed to some depository libraries in micr...

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.

United States. Congress. Senate. Committee on the Judiciary.

January 2004

"Serial no. J-108-34."Shipping list no.: 2004-0161-P.Distributed to some depository libraries in mic...

Drug safety and pricing : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... June 13, 2000.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2000

Shipping list no.: 2001-0035-P.Distributed to some depository libraries in microfiche.Includes bibli...

Pharmaceutical marketplace reform : is competition the right prescription? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, November 16, 1993.

United States. Congress. Senate. Special Committee on Aging.

January 1994

"Serial no. 103-15."Shipping list no.: 94-0071-P.Distributed to some depository libraries in microfi...

Health insurance : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eighth Congress, first session : special hearing, May 14, 2003, Washington, DC.

United States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.

January 2003

Shipping list no.: 2004-0072-P.Distributed to some depository libraries in microfiche."Printed for t...

Technology, innovation, and health care costs : hearing before the Joint Economic Committee, Congress of the United States, One Hundred Eighth Congress, first session, July 9, 2003.

United States. Congress. Joint Economic Committee.

January 2003

Shipping list no.: 2004-0109-P.Distributed to some depository libraries in microfiche."Printed for t...

International trade and pharmaceuticals : joint hearing before the Subcommittee on International Trade and the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, April 27, 2004.

United States. Congress. Senate. Committee on Finance. Subcommittee on International Trade.
United States. Congress. Senate. Committee on Finance. Subcommittee on Health Care.

January 2004

Shipping list no.: 2005-0152-P.Distributed to some depository libraries in microfiche.Includes bibli...

Prescription drug costs : what drives increases? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, 106th Congress, 2nd session ... July 18, 2000.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2000

Shipping list no.: 2001-0024-P.Distributed to some depository libraries in microfiche."Printed for t...

The FDA and the future of American biomedical and food industries : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session, on examining activities of the Food and Drug Afministration focusing on the challenges and opportunities facing the pharmaceutical, biotech, medical device, and food industries, and FDA's regulation of these industries, April 5 and 6, 1995.

United States. Congress. Senate. Committee on Labor and Human Resources.

January 1995

Shipping list no.: 95-0243-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Medicare regulatory and contracting reform : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Eighth Congress, first session, February, 13, 2003.

United States. Congress. House. Committee on Ways and Means. Subcommittee on Health.

January 2003

"Serial no. 108-4."Shipping list no.: 2003-0220-P.Distributed to some depository libraries in microf...

Policy implications of pharmaceutical importation for U.S. consumers : hearing before the Subcommittee on Interstate Commerce, Trade, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Tenth Congress, first session, March 7, 2007.

United States. Congress. Senate. Committee on Commerce, Science, and Transportation. Subcommittee on Interstate Commerce, Trade, and Tourism.

January 2013

Shipping list no.: 2013-0150-P.Includes bibliographical references.Mode of access: Internet

The economic aspects of the pharmaceutical industry in the United States : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 25, 2003.

Abstract

Extracted data

The economic aspects of the pharmaceutical industry in the United States : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 25, 2003.

Abstract

Extracted data

Related items

Related items